Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Williams

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
Theranostics|October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancersAndrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
The EMBO Journal|March 14, 2013
Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative diseaseReza Sharifi, Rosa Morra, C Denise Appel, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
Research Square|August 3, 2021
Impact of natural selection on global patterns of genetic variation, and association with clinical phenotypes, at genes involved in SARS-CoV-2 infectionChao Zhang, Anurag Verma, Yuanqing Feng, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Disrupted Lipid Homeostasis as a Pathogenic Mechanism in ABCA7-Associated Alzheimers Disease RiskMargaret A Pericak-Vance, Younji Nam, Brooke A DeRosa, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
The Lancet. Oncology|April 2, 2026
[<sup>177</sup>Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 studyShahneen Sandhu, Anthony M Joshua, Louise Emmett, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023Edmund Chiong, Declan G Murphy, Nicholas Buchan, et al.
Cell|July 11, 2020
A Genetic Map of the Response to DNA Damage in Human CellsMichele Olivieri, Tiffany Cho, Alejandro Álvarez-Quilón, et al.
The Journal of Pathology|October 26, 2022
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primaryAtara Posner, Owen Wj Prall, Tharani Sivakumaran, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
Theranostics|October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancersAndrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
The EMBO Journal|March 14, 2013
Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative diseaseReza Sharifi, Rosa Morra, C Denise Appel, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
Research Square|August 3, 2021
Impact of natural selection on global patterns of genetic variation, and association with clinical phenotypes, at genes involved in SARS-CoV-2 infectionChao Zhang, Anurag Verma, Yuanqing Feng, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Disrupted Lipid Homeostasis as a Pathogenic Mechanism in ABCA7-Associated Alzheimers Disease RiskMargaret A Pericak-Vance, Younji Nam, Brooke A DeRosa, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
The Lancet. Oncology|April 2, 2026
[<sup>177</sup>Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 studyShahneen Sandhu, Anthony M Joshua, Louise Emmett, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023Edmund Chiong, Declan G Murphy, Nicholas Buchan, et al.
Cell|July 11, 2020
A Genetic Map of the Response to DNA Damage in Human CellsMichele Olivieri, Tiffany Cho, Alejandro Álvarez-Quilón, et al.
The Journal of Pathology|October 26, 2022
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primaryAtara Posner, Owen Wj Prall, Tharani Sivakumaran, et al.
Pageof 27